Meenu Chhabra - Feb 23, 2022 Form 3 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
Feb 23, 2022
Transactions value $
$0
Form type
3
Date filed
3/9/2022, 04:01 PM
Next filing
Aug 8, 2022

No securities are beneficially owned.

Remarks:

Reported late due to administrative error. Exhibit 24 - Power of Attorney